Eli Lilly and CompanyvsOmada Health

LLY and OMDA stock compared: price, dividend, valuation and results, from SEC filings.

LLY

Eli Lilly and Company

$1,382.75

Value $1.30T

-2.32%
LLY's page

Eli Lilly and Company (LLY) has a market value of $1.30T and Omada Health (OMDA) $817M. Over the last year, with dividends, LLY moved +36.2% and OMDA -32.3%. The P/E is 47.3 for LLY and 58.2 for OMDA. Dividend yield: LLY 0.46%, OMDA none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    LLY$1.30T

    OMDA$817M

    LLY is 1,597 times OMDA

  • Revenue, 12 months

    LLY$86.5B

    OMDA$333M

    LLY is 260 times OMDA

  • Net income, 12 months

    LLY$27.6B

    OMDA$14M

    LLY is 1,965 times OMDA

  • Operating margin

    LLY–

    OMDA2.1%

  • ROIC

    LLY35.5%

    OMDA2.3%

    33.2 points apart

  • P/E

    LLY47.3

    OMDA58.2

    OMDA is 1.2 times LLY

  • Dividend yield

    LLY0.5%

    OMDA0.0%

    0.5 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

LLY+36.2%

OMDA-32.3%

75100125DecFebAprJunAugOct
Returns by period
PeriodLLYWith dividendsOMDAWith dividends
1 year since November 17, 2025+36.2%Price +35.3%-32.3%Price -32.3%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

LLYEli Lilly and CompanyOMDAOmada Health

Valuation

LLYOMDA
Valuation
Price$1,382.75$13.17
Market value$1.30T$817M
Enterprise value (EV)$1.35T$574M
P/E47.358.2
P/E, 5-year median49.9–
P/B32.43.0
EV/EBIT38.883.6
Free cash flow yield1.5%3.5%

Results and growth

LLYOMDA
Results and growth
Revenue, 12 months$86.5B$333M
Net income, 12 months$27.6B$14M
Free cash flow, 12 months$19.7B$28M
Earnings per share, 12 months$30.81$0.23
Revenue growth, year on year44.7%53.2%
Revenue growth a year, past+21.6%over 5 years+45.6%over 2 years
EPS growth a year, past+27.6%over 5 years–

Margins and returns on capital

LLYOMDA
Margins and returns on capital
Gross margin83.6%70.7%
Operating margin–2.1%
Net margin31.9%4.2%
ROIC35.5%2.3%
ROE88.6%5.8%

Balance sheet

LLYOMDA
Balance sheet
Cash$4.9B$243M
Total debt$49.5B$0
Net debt / EBITDA1.2-19.7
Interest cover38.9×22.4×

Dividends and buybacks

LLYOMDA
Dividends and buybacks
Dividend yield0.5%–
Dividend per share, 12 months$6.34–
Dividend growth a year, past+15.2%over 5 years–
Buyback yield0.3%–
Shareholder yield0.8%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: LLY or OMDA

Didn't find what you were looking for?

Ask us
Which is bigger, Eli Lilly and Company or Omada Health?

By market value, Eli Lilly and Company ($1.30T) is about 1,596.5 times Omada Health ($817M), at today's prices.

How did LLY and OMDA stock do over the last 1 years?

Since November 17, 2025, LLY's price moved +35.3% and OMDA's -32.3%. With dividends: LLY +36.2% (+36.2% a year), OMDA -32.3% (-32.3% a year). Past returns do not predict future ones.

Which pays the higher dividend, LLY or OMDA?

The dividend yield at today's price is 0.46% for Eli Lilly and Company and none for Omada Health. Over the last twelve months they paid $6.34 and – per share.

What is the P/E of LLY and OMDA?

At today's price, the P/E is 47.3 for LLY and 58.2 for OMDA. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Eli Lilly and Company or Omada Health?

Over the last twelve months, the net margin was 31.9% for Eli Lilly and Company and 4.2% for Omada Health, and the operating margin – and 2.1%. Revenue was $86.5B and $333M.

Which is the better investment, Eli Lilly and Company or Omada Health?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.